PEDIPPI

This brand name is authorized in Ireland, Netherlands, New Zealand.

Active ingredients

The drug PEDIPPI contains one active pharmaceutical ingredient (API):

1	Omeprazole UNII KG60484QX9 - OMEPRAZOLE
	Omeprazole, a racemic mixture of two enantiomers reduces gastric acid secretion through a highly targeted mechanism of action. It is a specific inhibitor of the acid pump in the parietal cell. It is rapidly acting and provides control through reversible inhibition of gastric acid secretion with once daily dosing.
	Read more about Omeprazole

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
PEDIPPI Powder for oral suspension	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A02BC01	Omeprazole	A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) → A02BC Proton pump inhibitors
Discover more medicines within A02BC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NL	Z-Index G-Standaard, PRK	104558
NZ	Medicines and Medical Devices Safety Authority	22292, 22293